Intellia Therapeutics’ $100 Million Common Stock Offering

Goodwin Procter acted as counsel to Intellia Therapeutics, while Latham & Watkins LLP represented the underwriters in the transaction. Intellia Therapeutics, Inc. announced the pricing of…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now